SGLT-2 Inhibitor use and liver-related and mortality outcomes in patients with type 2 diabetes and compensated cirrhosis.

BMC Med · 2026 · PMC12888456 · PMID 41526898

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the subgroup of patients with viral hepatitis ( n = 760 in each group), we observed a risk reduction of similar magnitude for the primary composite outcome (HR: 0.85, 95% CI: 0.71–1.03), although the association did not reach statistical significance because of the limited sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.